Skip to main content
Clinical Trials/EUCTR2014-002243-17-ES
EUCTR2014-002243-17-ES
Active, not recruiting
Phase 1

Conscious sedation for procedures in Dental and Minor Maxillofacial Surgery Unit: optimization of the dexmedetomidine dose (Dexdor®).

Clínica Universidad de Navarra/Universidad de Navarra0 sites124 target enrollmentJune 9, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Sedation for procedures in Dental and Minor Maxillofacial Surgery Unit
Sponsor
Clínica Universidad de Navarra/Universidad de Navarra
Enrollment
124
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2014
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Ability to provide informed consent and express his desire to meet all protocol requirements during the study.
  • 2\.The patient should be able to meet with all requirements of the clinical trial.
  • 3\.Above 18 years of age.
  • 4\.A pregnancy test will be performed to women between 18 years old and menopause in order to rule out pregnancy unknown.
  • 5\.The patient requires sedation to carry out one of the Dental procedures and Maxillofacial Surgery Unit: Complex wisdom 4 tooth extraction, Dental implants with or without bone stimulation.
  • 6\.Individuals ASA I (healthy patient) or II (patient with a process mild systemic without limitations in daily activities.)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 34

Exclusion Criteria

  • 1\.Dexmedetomidine hypersensitivity
  • 2\.HR \< 45bpm. Most individuals who participate in the study will be youth or individuals with hypertension controlled with drugs decrease HR \<60 bpm without any symptoms. So if the individual with HR\>45bpm does not shows sign of low cardiac output, he will be considered candidates for the study.
  • 3\.Heart block grade 2\-3 without pacemaker
  • 4\.Mean blood pressure \< 60mmHg.
  • 5\.Severe stroke.
  • 6\.Pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials